Brief: Apimeds Pharmaceuticals Appoints Youngjik Cho As Chairman Of Board
25/03/2026 11:20
March 25 (Reuters) - Apimeds Pharmaceuticals US Inc APUS.A: APIMEDS PHARMACEUTICALS - APPOINTS YOUNGJIK CHO AS CHAIRMAN OF THE BOARD - SEC FILING APIMEDS PHARMACEUTICALS- ON MAR 20, REMOVES ELONA KOGAN, JAKAP KOO, CAROL O'DONNELL, BENNETT WEINTRAUB AS DIRECTORS EFFECTIVE IMMEDIATELY - SEC FILING APIMEDS PHARMACEUTICALS US INC - REMOVES DR. VIN MENON AS CEO EFFECTIVE IMMEDIATELY - SEC FILING APIMEDS PHARMACEUTICALS US INC - APPOINTS YOUNGJIK CHO AS CEO AND JUNYOUNG YU AS SECRETARY EFFECTIVE IMMEDIATELY - SEC FILING Further company coverage: APUS.A ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Apimeds Pharmaceuticals US
See all newsBrief: Apimeds Pharmaceuticals Us Inc Vin Menon Continues To Serve As The Company’S Chief Executive Officer
Brief: Apimeds Pharmaceuticals Appoints Youngjik Cho As Chairman Of Board
Brief: Apimeds Pharmaceuticals Us Inc. Announces Material Breach Of Merger Agreement By Inscobee Inc And Apimeds Inc
Brief: E.F. Hutton Advises On Strategic Merger Between Apimeds And Mindwave
Brief: Apimeds And Mindwave Announce Merger, Integrating Biotech Growth With AI